Projected Growth of the Global Canine Arthritis Treatment Market to Reach $3.01 Billion by 2029

Uncover key drivers, emerging technologies, and competitive movements shaping the canine arthritis treatment market from 2025–2034 with trusted insights from The Business Research Company

What CAGR And Valuation Are Anticipated For The Canine Arthritis Treatment Market By The End Of 2029?

The sector dedicated to treating canine arthritis has experienced significant expansion lately, projecting an advancement from its 2024 valuation of $2.35 billion to $2.47 billion by 2025, translating to a compound annual growth rate of 5.3 during that span. This upward trajectory observed during the review period is fundamentally supported by several factors, including the increasing prevalence of older dogs, heightened consciousness among those who own pets regarding treatment options, a greater emphasis placed on prophylactic health measures, rising levels of discretionary spending, and greater overall spending on veterinary services.

Projected for substantial expansion in the forthcoming years, the market dedicated to treating arthritis in dogs is anticipated to reach a valuation of $3.01 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 5.0%; this upward trajectory during the projection timeframe is fundamentally supported by several factors, including the wider acceptance of pet insurance policies, an increasing incidence of arthritic conditions in dogs, escalating rates of pet humanization and ownership, the heightened need for surgical interventions that involve less tissue trauma, and the general increase in the frequency of this ailment among the canine population, while key developments shaping this sector involve the introduction of novel therapeutic modalities, progressive strides within veterinary science, a strong market pull for sophisticated treatment options, the incorporation of modern technological tools, and the emergence of state-of-the-art innovations.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16007&type=smp

Which Business Drivers Are Underpinning The Growth Of The Canine Arthritis Treatment Market?

Advancements in the number of individuals maintaining companion animals are projected to be a key force driving the expansion of the market for canine arthritis therapeutics hereafter. This concept of pet ownership encompasses the commitment and provisioning made by individuals or family units to ensure the welfare, necessities, and companionship for domesticated creatures kept mainly for enjoyment rather than practical service. Several elements, including shifts in living patterns, the increasing tendency to treat pets as family members, and greater amounts of discretionary funds, contribute to the upward trend in pet possession statistics. Guardians procure canine joint affliction therapies to effectively control and lessen the discomfort associated with arthritis in their dogs, their objective being to enhance their animal companions’ living standards and preserve their capacity to move freely. To illustrate this point, data released in October 2023 by the American Pet Products Association, a US-based organization operating on a non-profit basis, indicated that 86.9 million households across the United States harbored a pet, reflecting an ownership rate of 66% compared to the figures from 2022, consequently, this surge in household pet retention is fueling momentum in the market for canine arthritis remedies.

What Are The Principal Segment Types In The Canine Arthritis Treatment Market?

The canine arthritis treatment market covered in this report is segmented –

1) By Treatment Type: Drugs, Supplements, Surgical Procedures, Other Treatment Types

2) By Route Of Administration: Oral, Parenteral, Other Routes Of Administrations

3) By Arthritis Type: Osteoarthritis, Rheumatoid Arthritis, Osteochondrosis, Traumatic Arthritis

4) By Distribution Channels: Veterinary Clinics And Hospitals, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Drugs: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Disease-Modifying Osteoarthritis Drugs (DMOADs), Corticosteroids, Analgesics And Pain Relievers

2) By Supplements: Glucosamine And Chondroitin Supplements, Omega-3 Fatty Acids And Fish Oil, Hyaluronic Acid Supplements, MSM (Methylsulfonylmethane) Supplements, Collagen-Based Supplements

3) By Surgical Procedures: Joint Replacement Surgery, Arthroscopy, Osteotomy, Synovectomy

4) By Other Treatment Types: Physical Therapy, Stem Cell Therapy, Platelet-Rich Plasma (PRP) Therapy, Cold Laser Therapy (Low-Level Laser Therapy), Acupuncture

How Are Industry Trends Steering The Expansion Of The Canine Arthritis Treatment Market?

Leading enterprises within the veterinary arthritis sector are innovating therapeutic avenues, exemplified by the creation of bedinvetmab injections, specifically aimed at enhancing canine joint function and movement. This bedinvetmab preparation constitutes a monoclonal antibody delivered via injection, functioning through the identification and neutralization of nerve growth factor (NGF), a protein recognized for its role in transmitting pain within animal healthcare contexts. To illustrate, in May of 2023, Zoetis Inc., a prominent animal health corporation headquartered in the United States, secured authorization from the Food and Drug Administration (FDA) for Librela, this very bedinvetmab injectable product. It holds the distinction of being the inaugural monoclonal antibody (mAb) endorsed by the FDA for canine application, achieving its effect by attaching to and suppressing the biological pathways of canine nerve growth factor (NGF), which plays a part in governing the discomfort linked to osteoarthritis. Administration involves a monthly subcutaneous shot, positioning it as a straightforward and sustained approach for managing the persistent pain experienced by dogs suffering from osteoarthritis.

Which Companies Are Contributing Significantly To The Canine Arthritis Treatment Market Growth?

Major companies operating in the canine arthritis treatment market are Merck & Co. Inc., Bayer AG, Eli Lilly and Company, Zoetis Inc., Boehringer Ingelheim Animal Health, Elanco Animal Health Incorporated, Royal Canin SAS, Virbac Group, Ceva Sante Animale S.A., Hill’s Pet Nutrition Inc., Vetoquinol SA, Norbrook Laboratories Limited, American Regent Inc., Thorne Healthtech Inc., VetStem Inc., Eltech K-Laser s.r.l., Liquid Health Inc, Nutri-Vet LLC, OrthoPets LLC, Rejuvenate Bio Inc.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/canine-arthritis-treatment-global-market-report

Which Region Offers The Most Opportunity For Canine Arthritis Treatment Market Expansion?

North America was the largest region in the canine arthritis treatment market in 2024. Asia-Pacifica is expected to be the fastest-growing region in the forecast period. The regions covered in the canine arthritis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=16007&type=smp

Browse Through More Reports Similar to the Global Canine Arthritis Treatment Market 2025, By The Business Research Company

Fertility Treatments Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/fertility-treatments-global-market-report

Polycystic Ovarian Syndrome Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/polycystic-ovarian-syndrome-treatment-global-market-report

Alzheimer Disease Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/alzheimer-disease-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795